drugset / Trial / NCT07605052

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

NCT07605052

Phase 1 Active not recruiting 50 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this clinical study is to compare 2 different versions cagrilintide and see how these work in people living with excess body weight. Participant will get either cagrilintide B or cagrilintide D injections. Which treatment participant will get is decided by chance. Participant will be in this clinical study for about 14 weeks.

Timeline

Start
2026-05-20
Primary completion
2026-09-03
Completion
2026-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cagrilintide Protein / enzyme biologic Subcutaneous

Indications